These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18278999)

  • 1. [Treatment of cutaneous T-cell lymphoma with retinoid receptor X-selective ligands: endocrine and metabolic disorders].
    Avilés Pérez MD; Luna López V; Rodríguez Nevado I; de Argila Fernández-Durán D; Díaz Pérez de Madrid J
    An Med Interna; 2007 Dec; 24(12):595-8. PubMed ID: 18278999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma.
    Sherman SI
    Clin Lymphoma; 2003 Mar; 3(4):249-52. PubMed ID: 12672276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical and oral bexarotene.
    Schadt CR
    Dermatol Ther; 2013; 26(5):400-3. PubMed ID: 24099070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion.
    Assaf C; Bagot M; Dummer R; Duvic M; Gniadecki R; Knobler R; Ranki A; Schwandt P; Whittaker S
    Br J Dermatol; 2006 Aug; 155(2):261-6. PubMed ID: 16882161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
    Bohmeyer J; Stadler R; Kremer A; Nashan D; Muche M; Gellrich S; Luger T; Sterry W
    J Dtsch Dermatol Ges; 2003 Oct; 1(10):785-9. PubMed ID: 16281814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bexarotene therapy in folliculotropic cutaneous T-cell lymphoma].
    Drugeon C; Charlat I; Boulinguez S; Viraben R
    Ann Dermatol Venereol; 2007; 134(8-9):639-43. PubMed ID: 17925686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland.
    Väkevä L; Ranki A; Hahtola S
    Acta Derm Venereol; 2012 May; 92(3):258-63. PubMed ID: 22678563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.
    Duvic M
    Clin Lymphoma; 2000 Nov; 1 Suppl 1():S51-5. PubMed ID: 11707865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.
    Scarisbrick JJ; Morris S; Azurdia R; Illidge T; Parry E; Graham-Brown R; Cowan R; Gallop-Evans E; Wachsmuth R; Eagle M; Wierzbicki AS; Soran H; Whittaker S; Wain EM
    Br J Dermatol; 2013 Jan; 168(1):192-200. PubMed ID: 22963233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset bexarotene-induced CD4 lymphopenia in a cutaneous T-cell lymphoma patient.
    Eshagh K; Romero LS; So JK; Zhao XF
    Cutis; 2017 Feb; 99(2):E30-E34. PubMed ID: 28319634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central hypothyroidism associated with bexarotene therapy].
    Martin C; Bach-Ngohou K; Perrin B; Masson D
    Ann Biol Clin (Paris); 2006; 64(4):331-4. PubMed ID: 16829476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central hypothyroidism associated with retinoid X receptor-selective ligands.
    Sherman SI; Gopal J; Haugen BR; Chiu AC; Whaley K; Nowlakha P; Duvic M
    N Engl J Med; 1999 Apr; 340(14):1075-9. PubMed ID: 10194237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma.
    Cabello I; Servitje O; Corbella X; Bardés I; Pintó X
    Clin Exp Dermatol; 2017 Apr; 42(3):276-281. PubMed ID: 28233333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bexarotene: new preparation. Cutaneous lymphoma: too many adverse effects.
    Prescrire Int; 2004 Jun; 13(71):94-7. PubMed ID: 15233146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of cutaneous T-cell lymphomas with bexarotene].
    Lasa O; Izu R; Acebo E; Eguino P; Díaz-Pérez JL
    Actas Dermosifiliogr; 2005 Dec; 96(10):669-73. PubMed ID: 16476317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.
    Mehta N; Wayne AS; Kim YH; Hale GA; Alvarado CS; Myskowski P; Jaffe ES; Busam KJ; Pulitzer M; Zwerner J; Horwitz S
    Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):20-5. PubMed ID: 22001256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.
    Sokolowska-Wojdylo M; Florek A; Zaucha JM; Chmielowska E; Giza A; Knopinska-Posluszny W; Kulikowski W; Prejzner W; Romejko-Jarosinska J; Paszkiewicz-Kozik E; Osowiecki M; Walewski J; Rogowski W; Grzanka A; Placek W; Lugowska-Umer H; Kowalczyk A; Nowicki R; Jurczak W
    Am J Ther; 2016; 23(3):e749-56. PubMed ID: 24732904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing bexarotene therapy for cutaneous T-cell lymphoma.
    Talpur R; Ward S; Apisarnthanarax N; Breuer-Mcham J; Duvic M
    J Am Acad Dermatol; 2002 Nov; 47(5):672-84. PubMed ID: 12399758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial.
    Heald P; Mehlmauer M; Martin AG; Crowley CA; Yocum RC; Reich SD;
    J Am Acad Dermatol; 2003 Nov; 49(5):801-15. PubMed ID: 14576658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.
    Hamada T; Sugaya M; Tokura Y; Ohtsuka M; Tsuboi R; Nagatani T; Tani M; Setoyama M; Matsushita S; Kawai K; Yonekura K; Yoshida T; Saida T; Iwatsuki K
    J Dermatol; 2017 Feb; 44(2):135-142. PubMed ID: 27543197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.